| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Goetz Kathleen is a Director at abrdn Healthcare Opportunities Fund with holdings across 4 companies. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $76K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 | HQH Abrdn Healthcare Investors | Director | Buy | 525 | $16.42 | $8,622.39 | +94.7% | +7.7% | -9.4% | |
| Apr 9, 2024 | THW Abrdn World Healthcare Fund | Director | Buy | 200 | $12.53 | $2,506.00 | +24.5% | +3.6% | -17.1% | |
| Apr 9, 2024 | HQL Abrdn Life Sciences Investors | Director | Buy | 400 | $13.32 | $5,327.32 | +58.4% | +8.2% | -14.0% | |
| Apr 9, 2024 | THQ Abrdn Healthcare Opportunities Fund | Director | Buy | 600 | $19.54 | $11,722.86 | +109.5% | +5.2% | -2.7% | |
| Mar 23, 2022 | THQ Abrdn Healthcare Opportunities Fund | Director | Buy | 69 | $21.69 | $1,500.34 | +14.4% | -11.7% | -12.3% | |
| Mar 23, 2022 | HQH Abrdn Healthcare Investors | Director | Buy | 74 | $20.42 | $1,501.15 | +15.3% | -8.8% | -10.9% | |
| Mar 23, 2022 | THW Abrdn World Healthcare Fund | Director | Buy | 103 | $14.52 | $1,501.03 | +14.5% | -0.6% | -0.7% | |
| Mar 23, 2022 | HQL Abrdn Life Sciences Investors | Director | Buy | 92 | $16.27 | $1,501.85 | +15.6% | -13.0% | -12.8% | |
| Jan 26, 2022 | THW Abrdn World Healthcare Fund | Director | Buy | 714 | $14.60 | $10,425.61 | New | +8.7% | +10.4% | |
| Jan 26, 2022 | HQL Abrdn Life Sciences Investors | Director | Buy | 593 | $17.54 | $10,403.65 | New | -5.2% | -8.1% |